Lynch J P, Kazerooni E A, Gay S E
Department of Internal Medicine, University of Michigan Medical Center, Ann Arbor, Michigan, USA.
Clin Chest Med. 1997 Dec;18(4):755-85. doi: 10.1016/s0272-5231(05)70417-2.
Sarcoidosis involves the bronchi or lung in more than 90 percent of patients. Intrathoracic manifestations are protean, ranging from asymptomatic bilateral hilar lymphadenopathy to chronic, progressive, (ultimately fatal), respiratory insufficiency. The clinical course is highly variable, and optimal management and treatment are controversial. We review the salient radiographic, physiologic, and histopathologic features of pulmonary sarcoidosis and discuss rare intrathoracic complications (e.g., bronchostenosis, mycetomas, nodular sarcoidosis, necrotizing sarcoid angiitis and granulomatosis, pulmonary vascular and pleural involvement). We discuss the chest radiographic staging system and the role of ancillary diagnostic modalities including high resolution thin section computed tomographic scans (HRCT), bronchoalveolar lavage, radionuclide scan, and serum angiotensin enzyme converting enzyme. Indications for therapy and an overview of therapeutic options are outlined.
结节病累及超过90%的患者的支气管或肺部。胸内表现多种多样,从无症状的双侧肺门淋巴结肿大到慢性、进行性(最终致命)呼吸功能不全。临床病程差异很大,最佳管理和治疗存在争议。我们回顾了肺结节病的显著影像学、生理学和组织病理学特征,并讨论了罕见的胸内并发症(如支气管狭窄、曲菌球、结节性结节病、坏死性结节病血管炎和肉芽肿病、肺血管和胸膜受累)。我们讨论了胸部X线分期系统以及包括高分辨率薄层计算机断层扫描(HRCT)、支气管肺泡灌洗、放射性核素扫描和血清血管紧张素转换酶在内的辅助诊断方法的作用。概述了治疗指征和治疗选择。